Abstract PO1-03-11: Camrelizumab in Combination with Nab-Paclitaxel and Carboplatin Versus Nab-Paclitaxel and Carboplatin As Neoadjuvant Therapy for Triple Negative Breast Cancer: A Multicenter, Open-Label, Randomized Controlled Study
CANCER RESEARCH（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined